1. Home
  2. CGEN vs TOUR Comparison

CGEN vs TOUR Comparison

Compare CGEN & TOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • TOUR
  • Stock Information
  • Founded
  • CGEN 1993
  • TOUR 2006
  • Country
  • CGEN Israel
  • TOUR China
  • Employees
  • CGEN N/A
  • TOUR N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • TOUR Transportation Services
  • Sector
  • CGEN Health Care
  • TOUR Consumer Discretionary
  • Exchange
  • CGEN Nasdaq
  • TOUR Nasdaq
  • Market Cap
  • CGEN 142.4M
  • TOUR 117.7M
  • IPO Year
  • CGEN 2000
  • TOUR 2014
  • Fundamental
  • Price
  • CGEN $2.25
  • TOUR $1.00
  • Analyst Decision
  • CGEN Strong Buy
  • TOUR
  • Analyst Count
  • CGEN 1
  • TOUR 0
  • Target Price
  • CGEN $4.00
  • TOUR N/A
  • AVG Volume (30 Days)
  • CGEN 898.9K
  • TOUR 162.3K
  • Earning Date
  • CGEN 03-04-2025
  • TOUR 03-12-2025
  • Dividend Yield
  • CGEN N/A
  • TOUR N/A
  • EPS Growth
  • CGEN N/A
  • TOUR N/A
  • EPS
  • CGEN 0.02
  • TOUR N/A
  • Revenue
  • CGEN $59,852,000.00
  • TOUR $72,825,718.00
  • Revenue This Year
  • CGEN $57.27
  • TOUR $20.26
  • Revenue Next Year
  • CGEN N/A
  • TOUR $15.73
  • P/E Ratio
  • CGEN $125.59
  • TOUR N/A
  • Revenue Growth
  • CGEN 698.03
  • TOUR 38.57
  • 52 Week Low
  • CGEN $1.35
  • TOUR $0.59
  • 52 Week High
  • CGEN $3.03
  • TOUR $1.76
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 81.70
  • TOUR 48.92
  • Support Level
  • CGEN $1.92
  • TOUR $0.93
  • Resistance Level
  • CGEN $2.16
  • TOUR $1.05
  • Average True Range (ATR)
  • CGEN 0.15
  • TOUR 0.05
  • MACD
  • CGEN 0.07
  • TOUR 0.00
  • Stochastic Oscillator
  • CGEN 88.90
  • TOUR 60.00

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. All the company's revenues are derived from within the People's Republic of China.

Share on Social Networks: